1
|
Rugge M, Fassan M and Graham DY:
Epidemiology of gastric cancer. Gastric Cancer Springer. 23–34.
2015. View Article : Google Scholar
|
2
|
Chang WJ, Du Y, Zhao X, Ma LY and Cao GW:
Inflammation-related factors predicting prognosis of gastric
cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI
|
3
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
4
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
5
|
Ameres SL and Zamore PD: Diversifying
microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488.
2013. View
Article : Google Scholar : PubMed/NCBI
|
6
|
Dong H, Lei J, Ding L, Wen Y, Ju H and
Zhang X: MicroRNA: Function, detection, and bioanalysis. Chem Rev.
113:6207–6233. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Acunzo M, Romano G, Wernicke D and Croce
CM: MicroRNA and cancer-a brief overview. Adv Biol Regul. 57:1–9.
2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wen D, Danquah M, Chaudhary AK and Mahato
RI: Small molecules targeting microRNA for cancer therapy: Promises
and obstacles. J Control Release. 219:237–247. 2015. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hayes J, Peruzzi PP and Lawler S:
MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol
Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Zhao X, Dou W, He L, Liang S, Tie J, Liu
C, Li T, Lu Y, Mo P, Shi Y, et al: MicroRNA-7 functions as an
anti-metastatic microRNA in gastric cancer by targeting
insulin-like growth factor-1 receptor. Oncogene. 32:1363–1372.
2013. View Article : Google Scholar : PubMed/NCBI
|
11
|
Miao LJ, Huang SF, Sun ZT, Gao ZY, Zhang
RX, Liu Y and Wang J: MiR-449c targets c-Myc and inhibits NSCLC
cell progression. FEBS Lett. 587:1359–1365. 2013. View Article : Google Scholar : PubMed/NCBI
|
12
|
Sandbothe M, Buurman R, Reich N, Greiwe L,
Vajen B, Gürlevik E, Schäffer V, Eilers M, Kühnel F, Vaquero A, et
al: The microRNA-449 family inhibits TGF-β-mediated liver cancer
cell migration by targeting SOX4. J Hepatol. 66:1012–1021. 2017.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Adams BD, Kasinski AL and Slack FJ:
Aberrant regulation and function of microRNAs in cancer. Curr Biol.
24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
|
15
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. MicroRNA Cancer Regulation Springer.
1–20. 2012.
|
16
|
Clem BF, O'Neal J, Tapolsky G, Clem AL,
Imbert-Fernandez Y, Kerr DA II, Klarer AC, Redman R, Miller DM,
Trent JO, et al: Targeting 6-phosphofructo-2-kinase (PFKFB3) as a
therapeutic strategy against cancer. Mol Cancer Ther. 12:1461–1470.
2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Imbert-Fernandez Y, Clem A, Clem B,
Tapolsky G, Telang S and Chesney J: Suppression of
6-Phosphofructo-2-Kinase (PFKFB3) for the treatment of breast
cancer. AACR. 76:2016.
|